All Stories

  1. Incidental neuronal intermediate filament inclusion pathology: unexpected biopsy findings in a 37-year-old woman with epilepsy

    Article • Neuropathology and Applied Neurobiology, November 2017, Wiley

    Dr Katrin Beyer

  2. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies

    Article • Movement Disorders, March 2016, Wiley

    Dr Katrin Beyer

  3. Cystatin C is differentially involved in multiple system atrophy phenotypes

    Article • Neuropathology and Applied Neurobiology, May 2015, Wiley

    Dr Katrin Beyer

  4. Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for Neurodegeneration

    Article • Molecular Neurobiology, August 2012, Springer Science + Business Media

    Dr Katrin Beyer

  5. New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases

    Article • Neurogenetics, December 2011, Springer Science + Business Media

    Dr Katrin Beyer

  6. Alpha- and beta-synuclein expression in Parkinson disease with and without dementia

    Article • Journal of the Neurological Sciences, November 2011, Elsevier

    Dr Katrin Beyer

  7. The decrease of  -synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

    Article • Brain, October 2010, Oxford University Press (OUP)

    Dr Katrin Beyer

  8. Primary Renal Cell Carcinoma in a Transplanted Kidney: Genetic Evidence of Recipient Origin

    Article • Transplantation, April 2009, Wolters Kluwer Health

    Dr Katrin Beyer

  9. Molecular Pathology of Lewy Body Diseases

    Article • International Journal of Molecular Sciences, February 2009, MDPI AG

    Dr Katrin Beyer

  10. The Therapeutical Potential of Alpha-Synuclein Antiaggregatory Agents for Dementia with Lewy Bodies

    Article • Current Medicinal Chemistry, November 2008, Bentham Science Publishers

    Dr Katrin Beyer

  11. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease

    Article • Neurogenetics, July 2008, Springer Science + Business Media

    Dr Katrin Beyer

  12. Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences

    Article • Journal of Neuropathology & Experimental Neurology, November 2007, Oxford University Press (OUP)

    Dr Katrin Beyer

  13. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases

    Article • Neurogenetics, October 2007, Springer Science + Business Media

    Dr Katrin Beyer

  14. Parkin and synphilin-1 isoform expression changes in Lewy body diseases

    Article • Neurobiology of Disease, June 2007, Elsevier

    Dr Katrin Beyer

  15. A variable poly-T sequence modulates α-synuclein isoform expression and is associated with aging

    Article • Journal of Neuroscience Research, January 2007, Wiley

    Dr Katrin Beyer

  16. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease

    Article • Neuroreport, August 2006, Wolters Kluwer Health

    Dr Katrin Beyer

  17. α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

    Article • Acta Neuropathologica, July 2006, Springer Science + Business Media

    Dr Katrin Beyer

  18. Age at Onset: An Essential Variable for the Definition of Genetic Risk Factors for Sporadic Alzheimer's Disease

    Article • Annals of the New York Academy of Sciences, January 2006, Wiley

    Dr Katrin Beyer

  19. Upregulation of amyloid precursor protein isoforms containing Kunitz protease inhibitor in dementia with Lewy bodies

    Article • Molecular Brain Research, November 2004, Elsevier

    Dr Katrin Beyer

  20. Differential expression of α-synuclein isoforms in dementia with Lewy bodies

    Article • Neuropathology and Applied Neurobiology, July 2004, Wiley

    Dr Katrin Beyer

  21. Cystathionine Beta Synthase as a Risk Factor for Alzheimer Disease

    Article • Current Alzheimer Research, May 2004, Bentham Science Publishers

    Dr Katrin Beyer

  22. The homocysteine pathway: A new target for Alzheimer disease treatment?

    Article • Drug Development Research, January 2004, Wiley

    Dr Katrin Beyer

  23. Methionine synthase polymorphism is a risk factor for Alzheimer disease

    Article • Neuroreport, July 2003, Wolters Kluwer Health

    Dr Katrin Beyer

  24. Methionine synthase polymorphism is a risk factor for Alzheimer disease

    Article • Neuroreport, July 2003, Wolters Kluwer Health

    Dr Katrin Beyer

  25. Identification of a protective allele against Alzheimer disease in the APOE gene promoter

    Article • Neuroreport, August 2002, Wolters Kluwer Health

    Dr Katrin Beyer

  26. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset

    Article • Neuroscience Letters, July 2002, Elsevier

    Dr Katrin Beyer

  27. Alzheimer’s disease and the cystatin C gene polymorphism: an association study

    Article • Neuroscience Letters, November 2001, Elsevier

    Dr Katrin Beyer